Marco Radukic

Marco Radukic, PhD, is a researcher at Bielefeld University affiliated with the Faculty of Engineering's Cellular and Molecular Biotechnology Group. His work focuses on adeno-associated virus (AAV) engineering, plasmid design, and synthetic biology applications for gene therapy.

Research Interests

• Optimization of AAV production systems
• ITR (inverted terminal repeat) stability in bacterial hosts
• Cell-free viral assembly
• Lipid nanoparticle-mediated gene delivery
• High-throughput bioprocessing techniques

Publication Trends

Dr. Radukic's recent publications (2019-2025) focus on AAV vector engineering, bacterial expression systems for viral components, and nanopore sequencing applications for quality control. His work bridges molecular biology with biotechnology to improve recombinant AAV production methodologies.

Labs and Collaborations

He operates within Bielefeld University's Cellular and Molecular Biotechnology Group, which is part of Germany's broader biotechnology research ecosystem. His research involves collaborations with bioinformatics and biophysics groups as indicated by his methodological approaches.